Nanjing Immunophage Biotech Co., Ltd

This study is testing a new drug, IPG1094, in about 60 adults with advanced solid tumors that cannot be cured by surgery. The goal is to find a safe dose and see if the drug can shrink tumors. The study has two parts: first, finding the right dose, then testing that dose in more …

This early-stage study tests an experimental drug called IPG11406 in 36 people with lupus nephritis, a kidney complication of lupus. The main goals are to check if the drug is safe and tolerable, and to see early signs it might help kidney function. Participants take the drug by …

This early-stage study tests an experimental oral drug, IPG7236, in adults with advanced solid tumors that have spread or cannot be removed. The main goals are to check safety, find the best dose, and see if the drug can shrink tumors. About 196 participants will take the pill tw…